C
Charles M. Perou
Researcher at University of North Carolina at Chapel Hill
Publications - 645
Citations - 235604
Charles M. Perou is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 156, co-authored 573 publications receiving 202951 citations. Previous affiliations of Charles M. Perou include North Carolina Central University & University of Chicago.
Papers
More filters
Journal ArticleDOI
Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer
Michael D. Iglesia,Benjamin G. Vincent,Joel S. Parker,Katherine A. Hoadley,Lisa A. Carey,Charles M. Perou,Jonathan S. Serody +6 more
TL;DR: Improved metastasis-free/progression-free survival was correlated with B-cell gene expression signatures, which were restricted mainly to the basal-like and HER2-enriched breast cancer subtypes and the immunoreactive ovarian cancer subtype, suggesting the presence of a productive and potentially restricted antitumor B- cell response in basal- like breast and immunore active ovarian cancers.
Journal ArticleDOI
Defining the cellular precursors to human breast cancer.
Patricia J. Keller,Lisa M. Arendt,Adam Skibinski,Tanya Logvinenko,Ina Klebba,Shumin Dong,Avi Smith,Aleix Prat,Charles M. Perou,Hannah Leah Gilmore,Stuart J. Schnitt,Stephen P. Naber,Jonathan A. Garlick,Charlotte Kuperwasser +13 more
TL;DR: It is reported that transformation of EpCAM+ epithelial cells results in the formation of common forms of human breast cancer, including estrogen receptor-positive and estrogen receptors-negative tumors with luminal and basal-like characteristics, respectively, whereas transformation of CD10+ cells results
Journal ArticleDOI
Merging two gene-expression studies via cross-platform normalization
TL;DR: The proposed normalization method is applied to three existing breast cancer datasets, and is compared to several competing normalization methods using the proposed validation measures.
Journal ArticleDOI
MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
Jessica Bockhorn,Rachel Dalton,Chika Nwachukwu,Simo Huang,Aleix Prat,Kathy Yee,Ya Fang Chang,Dezheng Huo,Yujia Wen,Kaitlin E. Swanson,Tyler Qiu,Jun Lu,Seo Young Park,M. Eileen Dolan,Charles M. Perou,Olufunmilayo I. Olopade,Michael F. Clarke,Geoffrey L. Greene,Huiping Liu,Huiping Liu +19 more
TL;DR: It is demonstrated that microRNA-30c is transcriptionally regulated by GATA3 in breast tumours and inversely correlates with interleukin-11 expression in primary breast tumour patients, and low interleuko-11 correlates with relapse-free survival in breast cancer patients.
Journal ArticleDOI
The Integrated Genomic Landscape of Thymic Epithelial Tumors
Milan Radovich,Curtis R. Pickering,Ina Felau,Gavin Ha,Hailei Zhang,Heejoon Jo,Katherine A. Hoadley,Pavana Anur,Jiexin Zhang,Michael D. McLellan,Reanne Bowlby,Thomas Matthew,Ludmila Danilova,Apurva M. Hegde,Jaegil Kim,Mark D.M. Leiserson,Geetika Sethi,Charles Lu,Michael Ryan,Xiaoping Su,Andrew D. Cherniack,Gordon Robertson,Rehan Akbani,Paul T. Spellman,John N. Weinstein,D. Neil Hayes,Ben Raphael,Tara M. Lichtenberg,Kristen M. Leraas,Jean C. Zenklusen,Adrian Ally,Elizabeth L. Appelbaum,J. Todd Auman,Miruna Balasundaram,Saianand Balu,Madhusmita Behera,Rameen Beroukhim,Mario Berrios,Giovanni Blandino,Tom Bodenheimer,Moiz S. Bootwalla,Jay Bowen,Denise Brooks,Flavio Mavignier Carcano,Rebecca Carlsen,André Lopes Carvalho,Patricia Castro,Lara Chalabreysse,Lynda Chin,Juok Cho,Gina Choe,Eric Chuah,Sudha Chudamani,Carrie Cibulskis,Leslie Cope,Matthew G. Cordes,Daniel Crain,Erin Curley,Timothy Defreitas,John A. Demchok,Frank C. Detterbeck,Noreen Dhalla,Hendrik Dienemann,W. Jeff Edenfield,Francesco Facciolo,Martin L. Ferguson,Scott Frazer,Catrina Fronick,Lucinda Fulton,Robert S. Fulton,Stacey Gabriel,Johanna Gardner,Julie M. Gastier-Foster,Nils Gehlenborg,Mark Gerken,Gad Getz,David I. Heiman,Shital Hobensack,Andrea Holbrook,Robert A. Holt,Alan P. Hoyle,Carolyn M. Hutter,Michael Ittmann,Stuart R. Jefferys,Corbin D. Jones,Steven J.M. Jones,Katayoon Kasaian,Patrick K. Kimes,Phillip H. Lai,Peter W. Laird,Michael S. Lawrence,Pei Lin,Jia Liu,Laxmi Lolla,Yiling Lu,Yussanne Ma,Dennis T. Maglinte,David Mallery,Elaine R. Mardis,Marco A. Marra,Julie S. Martin,Michael Mayo,Sam Meier,Michael Meister,Shaowu Meng,Matthew Meyerson,Piotr A. Mieczkowski,Christopher A. Miller,Gordon B. Mills,Richard A. Moore,Scott Morris,Lisle E. Mose,Thomas Muley,Andrew J. Mungall,Karen Mungall,Rashi Naresh,Yulia Newton,Michael S. Noble,Taofeek K. Owonikoko,Joel S. Parker,Joseph Paulaskis,Robert Penny,Charles M. Perou,Corinne Perrin,Todd Pihl,Amie Radenbaugh,Suresh S. Ramalingam,Nilsa C. Ramirez,Ralf J. Rieker,Jeffrey Roach,Sara Sadeghi,Gordon Saksena,Jacqueline E. Schein,Heather Schmidt,Steven E. Schumacher,Candace Shelton,Troy Shelton,Yan Shi,Juliann Shih,Gabriel Sica,Henrique César Santejo Silveira,Janae V. Simons,Payal Sipahimalani,Tara Skelly,Heidi J. Sofia,Matthew G. Soloway,Joshua M. Stuart,Qiang Sun,Angela Tam,Donghui Tan,Roy Tarnuzzer,Nina Thiessen,David Van Den Berg,Mohammad A. Vasef,Umadevi Veluvolu,Doug Voet,Vonn Walter,Yunhu Wan,Zhining Wang,Arne Warth,Cleo-Aron Weis,Daniel J. Weisenberger,Matthew D. Wilkerson,Lisa Wise,Tina Wong,Hsin-Ta Wu,Ye Wu,Liming Yang,Jiashan Zhang,Erik Zmuda,Junya Fujimoto,Cristovam Scapulatempo-Neto,Andre L. Moreira,David M. Hwang,James Huang,Mirella Marino,Robert Korst,Giuseppe Giaccone,Yesim Gökmen-Polar,Sunil Badve,Arun Rajan,Philipp Ströbel,Nicolas Girard,Ming-Sound Tsao,Alexander Marx,Anne S. Tsao,Patrick J. Loehrer +186 more
TL;DR: A molecular link between thymoma and the autoimmune disease myasthenia gravis is identified, characterized by tumoral overexpression of muscle autoantigens, and increased aneuploidy.